Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclatasvir Single Ascending Dose in Chronic HCV
NCT00546715Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of daclatasvir in hepatitis C (HCV), sponsored by Bristol Myers Squibb. Started Nov 2007; status: completed.
02
Drugs
daclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00546715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00546715.